Anokion Announces the Early Completion of Enrollment in the ACeD-it Phase 2 and the SynCeD Phase 2a Trials of KAN-101 for the Treatment of Celiac Disease [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Celiac Disease is a serious autoimmune disease that currently has no approved therapeutic treatments CAMBRIDGE, Mass. & LAUSANNE, Switzerland, December 19, 2024 BUSINESS WIRE Anokion SA , a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced the early completion of patient dosing in the Phase 2 ACeD-it and Phase 2a SynCeD trials of KAN-101, a potential disease-modifying treatment for celiac disease. Topline data from both the Phase 2 ACeD-it and Phase 2a SynCeD clinical trials are expected in the first half of 2025. KAN-101 is a novel immune tolerance therapy, which encompasses an established gluten antigen delivered to the liver and im
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Drugmakers to raise US prices on over 250... [USA TODAY]USA TODAY
- Fewer rate cuts will boost banks in 2025. Here's how. [Yahoo! Finance]Yahoo! Finance
- Sangamo stock plummets 50% after Pfizer ends gene therapy deal [Yahoo! Finance]Yahoo! Finance
- Why did Pfizer's exit from the gene therapy program hit Sangamo hard? [Seeking Alpha]Seeking Alpha
- SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 10/29/24 - Beat
PFE
Sec Filings
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- 12/17/24 - Form 8-K
- PFE's page on the SEC website